Copenhagen-based Scandinavian Biolabs gets €4 million to expand hair-loss product in Europe
Summary
Scandinavian Biolabs (SBL), a Danish innovator in the haircare industry, announced the closing of a €4 million investment round led by Auréa Group marking a significant milestone along the company’s growth journey. Founded in 2020, Scandinavian Biolabs has established itself as a leader in science-backed, non-invasive, preventative products targeting early-stage hair loss. Scandinavian Biolabs initially launched as a direct-to-consumer (DTC) brand, rapidly building a loyal customer base through its online platform. We are excited to be joined by our new investors who can help us leapfrog our growth through their experience and know-how.” With over 140,000 customers supported so far, and a Trustpilot score of 4.5 out of 5, Scandinavian Biolabs is on a fast track to become the preferred solution for reliable, tested and honest hair-care products that work with your body. The €4 million cash infusion from Auréa will enable Scandinavian Biolabs to pursue its ambitious growth plans more aggressively forging a leadership position in the UK, Germany, and the Nordics, while also entering the US market, scaling the business through an online offering, and expanding strategic retail such as pharmacies.